Regeneron Pharmaceuticals Inc. and Sanofi and must assess how their experimental cholesterol drug affects brain function after U.S. regulators learned of adverse events associated with this new class of medicines.
Seritage Realty Trust’s homepage seeks to dazzle prospective tenants with illustrations of gleaming retail properties featuring landscaped parking lots filled with cars and shoppers. Seritage promises visitors “the locations you need in virtually every major U.S. market.”
Amgen Inc. completed a fifth late- stage study of its experimental anti-cholesterol medicine, leading competitors that are trying to bring a new class of therapies to a market estimated to be worth billions.
Amgen Inc., the biotechnology company that completed its $10.4 billion acquisition of Onyx Pharmaceuticals Inc. this month, boosted its 2013 forecast after third-quarter earnings rose 24 percent on higher drug sales.